Heptares is a clinical-stage company creating novel medicines targeting G protein-coupled receptors (GPCRs), a superfamily of receptors linked to a wide range of human diseases. Our proprietary structure-based drug design platform has enabled us to build an exciting pipeline of new medicines with potential to transform the treatment of Alzheimer’s disease, ADHD, diabetes, schizophrenia, migraine, and other diseases. Our ability to address highly validated, yet historically undruggable, GPCRs has also attracted multiple partners including AstraZeneca, Cubist, Morphosys and Takeda.
Heptares Therapeutics is establishing itself as a leading drug discovery company based on its GPCR expertise and transformational StaR® technology. We welcome the interest of talented, enthusiastic and motivated candidates looking to work in a dynamic, fast-moving environment.